Orchestra BioMed Holdings, Inc. Logo

Orchestra BioMed Holdings, Inc.

Develops therapeutic products for unmet needs in procedure-based medicine.

OBIO | US

Overview

Corporate Details

ISIN(s):
KYG4411D1097 (+1 more)
LEI:
Country:
United States of America
Address:
150 UNION SQUARE DRIVE, 18938 NEW HOPE

Description

Orchestra BioMed Holdings, Inc. is a biomedical innovation company focused on developing therapeutic products for unmet clinical needs in procedure-based medicine. The company's business model is centered on accelerating high-impact technologies to patients through risk-reward sharing partnerships with established medical device companies. Its flagship product candidates include Atrioventricular Interval Modulation (AVIM) Therapy, an investigational bioelectronic treatment designed to reduce blood pressure in patients with hypertension, and the Virtue® Sirolimus AngioInfusion™ Balloon (SAB). Virtue SAB is an investigational drug/device combination product for treating artery disease by delivering an extended-release formulation of sirolimus during angioplasty without requiring a permanent implant or coated balloon.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Orchestra BioMed Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Orchestra BioMed Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Orchestra BioMed Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

3-D Matrix,Ltd. Logo
Develops peptide-based hydrogels to control bleeding in surgical procedures.
Japan
7777
aap Implantate AG Logo
Develops, manufactures, and markets implants for the treatment of bone fractures.
Germany
AAQ1
AcouSort AB Logo
Develops acoustofluidic solutions for automated biological sample processing.
Sweden
ACOU
Adagio Medical Holdings, Inc. Logo
Develops cryoablation technologies for treating cardiac arrhythmias like VT.
United States of America
ADGM
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for surgery and woundcare.
United Kingdom
AMS
AETHLON MEDICAL INC Logo
Develops immunotherapeutic devices to deplete exosomes and viruses from the blood.
United States of America
AEMD
Affluent Medical Logo
Develops minimally invasive implants for structural heart disease and urology.
France
AFME
AIOBIO Co., Ltd. Logo
Develops AI-driven diagnostic platforms and imaging devices for dental care.
South Korea
447690
Airway Medix S.A. Logo
Develops single-use medical devices for mechanically ventilated patients.
Poland
AWM
ALIGN TECHNOLOGY INC Logo
Designs and manufactures clear aligners, intraoral scanners, and digital services.
United States of America
ALGN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.